Connect Biopharma Holdings (CNTB) Other financing activities (2024 - 2026)

Connect Biopharma Holdings (CNTB) posted Other financing activities of $18.6 million for Q1 2026, up 2806.25% sequentially from $640000.0 in Q4 2025.

Connect Biopharma Holdings (CNTB) Other financing activities (2024 - 2026) Analysis & Trends

Connect Biopharma Holdings has reported Other financing activities for 3 years, with the latest figure at $18.6 million in Q1 2026.

Quarterly Other financing activities changed N/A year-over-year to $18.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.5 million (up 9938.66% YoY) and the FY2025 annual result came in at $875000.0, up 351.03% from the prior year.
Other financing activities grew to $18.6 million in Q1 2026 per CNTB's latest filing, from $640000.0 in the prior quarter.
Over five years, Other financing activities peaked at $18.6 million in Q1 2026 and troughed at $92000.0 in Q3 2025.
A 3-year average of $3.3 million and a median of $122000.0 in 2024 frame the typical range for Other financing activities.
The widest YoY moves for Other financing activities: up 588.17% in 2025, down 41.58% in 2025.
Over 3 years, Other financing activities stood at $93000.0 in 2024, then jumped by 588.17% to $640000.0 in 2025, then jumped by 2806.25% to $18.6 million in 2026.
According to Business Quant data, Other financing activities over the past three periods registered $18.6 million, $640000.0, and $92000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Connect Biopharma Holdings	148.41 Mn	148.41 Mn	-

Download Data